A 29-year-old woman is evaluated in the hospital prior to discharge. Three days ago, she was admitted with severe lower abdominal pain, a temperature of (), a blood pressure of , and a heart rate of . Pelvic examination at that time revealed purulent cervical discharge, pronounced cervical motion tenderness, and a palpable, tender left adnexal mass. A copper intrauterine device string was visible at the cervical os. Pelvic ultrasonography confirmed a left tubo-ovarian abscess. She was admitted and started on intravenous cefoxitin and oral doxycycline. Over the past 72 hours, she has become afebrile, her heart rate has decreased to , and her pelvic pain has significantly improved. Her leukocyte count has normalized to . She is currently tolerating a regular diet. Endocervical nucleic acid amplification testing from admission returned positive for *Chlamydia trachomatis* and negative for *Neisseria gonorrhoeae*. Blood cultures show no growth. She will be discharged to complete a 14-day total course of therapy. Which of the following is the most appropriate next step in management?
- Retain the intrauterine device; prescribe oral doxycycline and oral metronidazoleAnswer
- BRetain the intrauterine device; prescribe oral doxycycline alone
- CRetain the intrauterine device; prescribe outpatient intravenous piperacillin-tazobactam
- DRemove the intrauterine device; prescribe oral doxycycline and oral metronidazole
- ERemove the intrauterine device; prescribe oral doxycycline alone